Drug Search by Year (Detail)

26679730

EU

Pain, Gait disturbance,

ARIPIPRAZOLE,

26679739

CA

Sleep disorder due to general medical condition, insomnia type, Musculoskeletal pain, Sciatica, Pain, Sinusitis, Synovitis, Weight increased, Liver disorder, Musculoskeletal stiffness, Nasopharyngitis, Weight decreased, Vomiting, Swelling, Urticaria, Paraesthesia, Lung disorder, Stomatitis, Treatment failure, Lower limb fracture, Wound infection, Decreased appetite, Contraindicated product administered, Deep vein thrombosis postoperative, Confusional state, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Gastrointestinal disorder, Product use in unapproved indication,

OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB,

26680088

US

Pain in extremity, Gait disturbance, Muscle spasms, Limb discomfort, General physical health deterioration, Malaise, Fall,

RAVULIZUMAB,

26680471

CA

Facial paralysis, Fall, Febrile neutropenia, Fine motor skill dysfunction, Gait disturbance, Hemiparesis, Hemiplegia, Immobile, Mastication disorder, Muscular weakness, Pyrexia,

METHOTREXATE, METHOTREXATE SODIUM, LORAZEPAM, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VINCRISTINE SULFATE,

26680552

CA

Pneumonia, Pyrexia, Nervousness, Vomiting, Malaise, Pyrexia, Influenza, Gait disturbance, Condition aggravated, Brain fog, Surgery, Blood sodium decreased,

DUPILUMAB, OXYCODONE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, BENZOYL PEROXIDE, SALICYLIC ACID,

26681003

CA

Deep vein thrombosis postoperative, Gastrointestinal disorder, Overdose, Dizziness, Decreased appetite, Glossodynia, Diarrhoea, Gait disturbance, Depression, Off label use, Discomfort, Contraindicated product administered, Drug intolerance, General physical health deterioration, Dyspnoea, Facet joint syndrome, Dry mouth, Drug hypersensitivity, Dyspepsia, Grip strength decreased, Duodenal ulcer perforation, Confusional state, Delirium, Dislocation of vertebra, Gait inability,

SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RISEDRONATE SODIUM, RISEDRONATE SODIUM, PREGABALIN, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CELECOXIB, CELECOXIB, CELECOXIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB,

26681335

Neuropathy peripheral, Pain, Gait disturbance, Temperature regulation disorder, Abdominal discomfort,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, PROGESTERONE, ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS),

26686210

Fatigue, Gait disturbance,

UBLITUXIMAB,

26687091

Arthralgia, Gait disturbance, Tendon rupture,

TIRZEPATIDE, TIRZEPATIDE, CALCIUM, CETIRIZINE HYDROCHLORIDE, EZETIMIBE, PREDNISONE, TIRZEPATIDE,

26672787

US

Injection site pain, Back pain, Gait disturbance,

ORAL SEMAGLUTIDE,

26672977

US

Muscle fatigue, Gait disturbance, Depression,

26673980

US

Gait disturbance, Arthralgia, Pain in extremity, Pain, Weight decreased, Pain in extremity,

INSULIN ASPART,

26674539

US

Muscle atrophy, Gait disturbance,

ORAL SEMAGLUTIDE,

26674692

US

Constipation, Dyspepsia, Nausea, Blood glucose increased, Blood calcium increased, Vision blurred, Pain, Insomnia, Parosmia, Gait disturbance,

26675349

US

Gait disturbance, Dysstasia, Weight increased,

26676073

US

Nausea, Dizziness, Ear congestion, Gait disturbance, Bradyphrenia, Ear discomfort, Vertigo,

26676088

US

Injection site pain, Gait disturbance, Weight loss poor, Product communication issue,

26676312

US

Fall, Gait disturbance,

DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE),

26676472

US

Gait disturbance, Formication, Visual impairment, Hypersensitivity, Vertigo, Vision blurred,

LUMATEPERONE,

26676588

JP

Gait disturbance, Fall, Head injury, Face injury, Mobility decreased,

ROMOSOZUMAB-AQQG,

26685580

Brain fog, Disturbance in attention, Headache, Fatigue, Gait disturbance, Muscular weakness, Tremor,

CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METRONIDAZOLE,

26671782

CA

Pneumonia, Asthenia, Gait disturbance,

BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE INHALATION SPRAY, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, LINAGLIPTIN,

26671986

US

Gait disturbance, On and off phenomenon, Device issue,

FOSCARBIDOPA/FOSLEVODOPA,

26672106

US

Fall, Gait disturbance,

ORAL SEMAGLUTIDE,

26672253

US

Asthenia, Fatigue, Gait disturbance, Feeling abnormal,

ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE,

26672368

US

Gait disturbance, Muscular weakness,

ORAL SEMAGLUTIDE,

26680709

Gait disturbance,

DIROXIMEL FUMARATE,

26666012

US

Speech disorder, Gait disturbance, Product substitution issue, Product quality issue,

PRAMIPEXOLE,

26666068

US

Gingival abscess, Osteoporosis, Arthritis, Tooth injury, Diarrhoea, Weight decreased, Urine output increased, Diarrhoea, Cardiac disorder, Swelling face, Asthma, Gingival injury, Motion sickness, Adverse drug reaction, Headache, Gastrointestinal tract irritation, Melanocytic naevus, COVID-19, Skin disorder, Hypophagia, Abdominal discomfort, Secretion discharge, Hyperkeratosis, Fatigue, Oral disorder, Tooth disorder, Urinary incontinence, Hypertension, Urinary tract infection, Gait disturbance, Pollakiuria, Flatulence, Bladder catheterisation, Infection,

IBRUTINIB, IBRUTINIB, IBRUTINIB, IBRUTINIB, IBRUTINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, DULOXETINE HYDROCHLORIDE, FISH OIL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, CYCLOSPORINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ERGOCALCIFEROL, DICLOFENAC SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLEDRONIC ACID, CETIRIZINE HYDROCHLORIDE,

26666332

US

Sepsis, Gait disturbance,

POMALIDOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, DARBEPOETIN ALFA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CLONAZEPAM, DULOXETINE HYDROCHLORIDE, DULOXETINE, SACCHAROMYCES CEREVISIAE, FUROSEMIDE, LANSOPRAZOLE, MAGNESIUM OXIDE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN, SERTRALINE, TORSEMIDE, ERGOCALCIFEROL,

26666371

CA

Fall, Gait disturbance, Heart rate decreased, Hip fracture, Lower respiratory tract infection, Malaise, Weight decreased, Urinary tract infection, Wrist fracture, Abdominal pain lower, Sinusitis, Nasopharyngitis, Abdominal pain upper, Cough, Drug hypersensitivity, Dizziness, Fatigue, Pyrexia, Off label use,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CICLESONIDE, PREDNISONE, SALMETEROL XINAFOATE,

26666372

CA

Asthma, Gait disturbance, Neuropathy peripheral,

OMALIZUMAB, PREDNISONE, PREDNISONE,

26666473

EU

Loss of consciousness, Dizziness, Syncope, Hallucination, On and off phenomenon, Dyskinesia, Gait disturbance, Hypotension, Restlessness, Delusion, Infusion site haematoma, Therapeutic product effect incomplete, Urinary tract infection,

FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA,

26666631

US

Dementia with Lewy bodies, Gait disturbance,

PIMAVANSERIN TARTRATE,

26666669

US

Gait disturbance, Constipation,

PIMAVANSERIN TARTRATE,

26666675

US

Discontinued product administered, Gait disturbance, Dysphagia,

TOPOTECAN HYDROCHLORIDE, TOPOTECAN, TOPOTECAN HYDROCHLORIDE, TOPOTECAN, FENTANYL, METHOCARBAMOL, METHOCARBAMOL TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, TAMSULOSIN HYDROCHLORIDE,

26666933

CA

Back pain, Blindness unilateral, Blood glucose decreased, Blood pressure increased, Contusion, Dysphagia, Dyspnoea, Gait disturbance, Glaucoma, Hand deformity, Heart rate increased, Hernia, Intervertebral disc compression, Intraocular pressure increased, Malaise, Musculoskeletal discomfort, Nephrolithiasis, Pneumonitis, Post procedural contusion, Respiratory rate increased, Weight decreased, Asthenia, Pneumonia, Sepsis, Tendon rupture, Urinary tract infection, Arthritis, Hypertension, Vertigo, Pain, Pain in extremity, Asthma, Drug hypersensitivity, Pruritus, Illness, Arthralgia,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROMORPHONE HYDROCHLORIDE, CICLESONIDE, PREDNISONE, MONTELUKAST SODIUM, ERGOCALCIFEROL,

26667115

EU

Mental impairment, Feeling abnormal, Feeling drunk, Gait disturbance,

PREGABALIN, ROSUVASTATIN,

26667308

US

Glaucoma, Dental caries, Gait disturbance, Product dose omission issue,

DALFAMPRIDINE,

26667757

US

Off label use, Cardiac failure chronic, Gout, Arthralgia, Gait disturbance, Gastrooesophageal reflux disease, Hypertensive heart disease, Carotid artery stenosis, Immunosuppression, Dementia, Type 2 diabetes mellitus, Renal impairment, Diabetic nephropathy, Hyperlipidaemia, Glaucoma, Laboratory test abnormal,

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, DONEPEZIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS, FAMOTIDINE, LISINOPRIL,

26667933

US

Dyspnoea, Gait disturbance, Speech disorder,

DAPAGLIFLOZIN, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLUOXETINE HYDROCHLORIDE, ALBUTEROL SULFATE, MACITENTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TADALAFIL, OXYGEN, 0XYGEN, BUMETANIDE, FERROUS SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,

26667987

AU

Dysstasia, Pain, Muscular weakness, Pain in extremity, Arthralgia, Loss of personal independence in daily activities, Painful respiration, Gait disturbance, Inappropriate schedule of product administration, Injection site pain, Limb discomfort, Chest discomfort, Fatigue, Discomfort, Impaired quality of life, Toxicity to various agents, Myalgia, Anxiety, Dyspnoea exertional, Asthenia, Exercise tolerance decreased, Impaired work ability, Arthropathy,

RISANKIZUMAB-RZAA,

26667999

Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Arthropathy, Condition aggravated, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Hypersensitivity, Liver injury, Nausea, Oedema, Mobility decreased, Muscular weakness, Psoriatic arthropathy, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Rash, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Weight decreased, Vomiting, Wheezing, Weight increased, Wound infection, Drug tolerance decreased, Drug intolerance, Drug ineffective, Maternal exposure during pregnancy, Off label use, Contraindicated product administered, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Therapeutic product effect decreased, Treatment failure, Underdose,

CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, LEFLUNOMIDE, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CALCIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE,

26668208

GB

Suicide attempt, Slow speech, Dysphemia, Gait disturbance, Cogwheel rigidity, Musculoskeletal stiffness, Tremor,

ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE,

26668542

GB

Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal,

DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, ACYCLOVIR, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, CEPHALEXIN, RIVAROXABAN, RIVAROXABAN,

26668562

CA

Gait disturbance, Micturition urgency, Diarrhoea, Fatigue, Yellow skin, Muscular weakness, Asthenia, Multiple sclerosis, Hypoaesthesia, Peroneal nerve palsy, Drug ineffective,

DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, OCRELIZUMAB, OCRELIZUMAB,

26668668

US

Cardiac operation, Psoriasis, Psoriatic arthropathy, Gait inability, Gait disturbance,

ADALIMUMAB, ADALIMUMAB,

26668933

BR

Fall, Sciatica, Gait disturbance, Motor dysfunction, Paresis, Gait disturbance, Intervertebral disc protrusion, Post procedural infection, Intervertebral discitis, Pain, Muscular weakness, Gait disturbance, Purulence, Pseudomonas infection, Acinetobacter infection, Expanded disability status scale score increased,

OCRELIZUMAB, DALFAMPRIDINE,

26668998

US

Autoscopy, Aggression, Brain fog, Tremor, Disorientation, Gait disturbance, Bacterial infection, White blood cell count decreased, Fatigue, Diarrhoea, Asthenia, Vomiting, Pyrexia,

PALBOCICLIB, PALBOCICLIB,

26669169

US

Gait disturbance, Condition aggravated, Pruritus, Arthritis, Skin ulcer,

DUPILUMAB,

26669397

EU

Haemoptysis, Pulmonary infarction, Aneurysm, Arteriovenous malformation, Myalgia, Arthralgia, Pelvic pain, Gait disturbance, Fall, Head injury, Joint injury, Limb injury, Skin laceration, Influenza, Diarrhoea, Muscular weakness, Off label use,

BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB,

26669470

GB

Cerebrovascular accident, Hypoaesthesia, Neutrophil count abnormal, Chromaturia, Productive cough, Pyrexia, Musculoskeletal chest pain, Decreased appetite, Feeling cold, Gait disturbance, Malaise, Balance disorder, Limb discomfort, Fall, Confusional state, Inappropriate schedule of product administration,

LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, ACYCLOVIR, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CEPHALEXIN,

26669573

CA

Sleep disorder due to general medical condition, insomnia type, Musculoskeletal pain, Sciatica, Pain, Sinusitis, Synovitis, Weight increased, Liver disorder, Musculoskeletal stiffness, Nasopharyngitis, Weight decreased, Vomiting, Swelling, Urticaria, Paraesthesia, Lung disorder, Stomatitis, Product use in unapproved indication, Treatment failure, Lower limb fracture, Wound infection, Decreased appetite, Contraindicated product administered, Deep vein thrombosis postoperative, Confusional state, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Gastrointestinal disorder,

SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB,

26669591

US

Systemic lupus erythematosus, Multiple sclerosis relapse, Pruritus, Joint dislocation, Limb injury, Hypokinesia, Walking aid user, Fall, Gait disturbance,

DALFAMPRIDINE,

26670139

CA

Hypersomnia, Osteoarthritis, Dysuria, Gait disturbance, Pain in extremity, Vision blurred, Plantar fasciitis,

INFLIXIMAB, INFLIXIMAB,

26670217

CA

Decreased appetite, Dysstasia, Gait disturbance, General physical health deterioration, Grip strength decreased, Hypokalaemia, Fatigue, Asthenia, C-reactive protein increased, Illness, Nausea, Pain, Drug ineffective,

HYDROXYCHLOROQUINE, METHOTREXATE SODIUM, SULFASALAZINE, CELECOXIB, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM,

26670536

US

Asthenia, Pain in extremity, Myalgia, Gait disturbance,

EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT),

26670869

US

Pulmonary embolism, Pain in extremity, Therapeutic response unexpected, Gait disturbance, Feeling cold, Mood swings, Musculoskeletal pain, Prostatic specific antigen decreased,

VUTRISIRAN, TAFAMIDIS MEGLUMINE, TAFAMIDIS MEGLUMINE, TAFAMIDIS, CHLORTHALIDONE, DAROLUTAMIDE, LOSARTAN,

26670999

EU

Diarrhoea, Neurological symptom, Gait disturbance, Irritability, Head injury, Dizziness, Fall, Sleep disorder,

26671026

Tinnitus, Pain in extremity, Gait disturbance, Drug ineffective,

CERTOLIZUMAB PEGOL, LEFLUNOMIDE, NAPROXEN, NAPROXEN SODIUM, ERGOCALCIFEROL,

26671304

US

Spinal stenosis, Hiatus hernia, Gait disturbance, Back injury,

26671529

EU

Leukaemia, Asthenia, Anal incontinence, Tremor, Dyskinesia, Speech disorder, Loss of personal independence in daily activities, Device occlusion, Mobility decreased, Poor quality sleep, Therapeutic product effect incomplete, Fatigue, Decreased activity, On and off phenomenon, Muscle rigidity, Dyskinesia, Catheter site swelling, Catheter site hypertrophy, Device loosening, Catheter site bruise, Infusion site hyperaesthesia, Stress, Hypophagia, Gait disturbance, Catheter site inflammation, Muscle spasms, Erysipelas, Drug ineffective, Muscle rigidity,

FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA,

26671565

CA

Seizure, Seizure, Anxiety, Gait disturbance, Partial seizures, Hyporesponsive to stimuli, Fatigue, Agitation, Aggression,

UPADACITINIB, LEVETIRACETAM, LEVETIRACETAM,

26679757

Asthenia, Pain in extremity, Pain in extremity, Gait disturbance,

TIRZEPATIDE, FAMOTIDINE, ERGOCALCIFEROL, MAGNESIUM, MELATONIN,

26684527

Plantar erythema, Pain in extremity, Gait disturbance, Pain in extremity, Pruritus, Paraesthesia, Erythema, Swelling, Insomnia,

GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, LACOSAMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, HYDROXYCHLOROQUINE, VIBEGRON, LOSARTAN, FLUTICASONE PROPIONATE,

26656665

US

Cough, Diarrhoea, COVID-19, Asthenia, Dyspnoea, Heart rate increased, Throat irritation, Gastrooesophageal reflux disease, Gait disturbance,

TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, RITUXIMAB, METHENAMINE HIPPURATE, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, OXYGEN, 0XYGEN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORATADINE, LORATADINE ORAL,

26657140

CN

Localised infection, Incision site impaired healing, Gait disturbance, Arthralgia, Muscular weakness,

DENOSUMAB,

26657191

US

Off label use, Malignant melanoma, Hypoacusis, Glomerular filtration rate decreased, Skin disorder, Gait disturbance, Blood alkaline phosphatase increased,

RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

26657213

US

Gait disturbance, Multiple sclerosis,

DIROXIMEL FUMARATE,

26657489

US

Gait disturbance, Peripheral swelling,

VIBEGRON,

26657712

CN

Condition aggravated, Memory impairment, Gait disturbance, Dizziness, Headache, Dysarthria,

DOCETAXEL, DOCETAXEL ANHYDROUS,

26657856

Hemiparesis, Fatigue, Gait disturbance,

CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LOSARTAN POTASSIUM, LOSARTAN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE,

26657927

US

Psoriatic arthropathy, Pain, Gait disturbance, Joint stiffness, Arthralgia, Dyspnoea, Therapeutic response decreased,

DUPILUMAB,

26657990

CA

Cerebral disorder, Epilepsy, Gait disturbance, Loss of consciousness, Malaise, Speech disorder, Weight decreased, Dry skin, Cerebrovascular accident, Headache, Pruritus, Product use in unapproved indication, Intentional product use issue,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, GLYCOPYRROLATE,

26658306

US

Gait disturbance, Neuropathy peripheral, Visual impairment,

INSULIN GLARGINE,

26658496

US

Cerebrovascular accident, Hepatotoxicity, Aphasia, Confusional state, Gait disturbance, Fatigue, Blood cholesterol increased, Fall, Blood alkaline phosphatase increased,

RESMETIROM, ATORVASTATIN CALCIUM,

26658504

CO

Tongue neoplasm malignant stage unspecified, Pneumonia, Noninfective sialoadenitis, Influenza, Arthralgia, Osteoarthritis, Gait disturbance,

DENOSUMAB,

26659208

US

Nausea, Diarrhoea, Feeding disorder, Gait disturbance,

ORAL SEMAGLUTIDE,

26659877

US

Gait disturbance, Pain in extremity, Alopecia, Diarrhoea,

TIRZEPATIDE, TIRZEPATIDE,

26659932

Musculoskeletal pain, Pain, Sciatic nerve injury, Gait disturbance, Pain in extremity, Pain in extremity,

PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, LANSOPRAZOLE, FOLIC ACID,

26660260

Loss of consciousness, Atrial flutter, Knee arthroplasty, Shoulder arthroplasty, Pain, Gait disturbance, Hypokinesia,

UPADACITINIB, UPADACITINIB, UPADACITINIB,

26660269

CA

Polyarthritis, Joint swelling, Nerve compression, Tinnitus, Gait disturbance, Neck pain, Pain, Hypoaesthesia, Blood creatinine increased, Drug intolerance, Electric shock sensation, Disease recurrence, Feeling abnormal, Hypersensitivity, Pain in extremity, Bursitis, Inflammation, Glomerular filtration rate decreased, Back pain, Inflammatory marker increased, Deafness, Limb discomfort, Musculoskeletal stiffness, Paraesthesia, Movement disorder, Arthralgia, Disease progression, Adverse event, Pain in jaw, Dry mouth, Tachycardia, Headache, Musculoskeletal discomfort,

LEFLUNOMIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, TOFACITINIB, LOSARTAN POTASSIUM, LOSARTAN, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ROSUVASTATIN CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,

26660654

US

Gait disturbance, Speech disorder, Unevaluable event, Photosensitivity reaction, Vomiting, Nausea, Nausea,

26660709

EU

General physical health deterioration, Pyrexia, Myalgia, Cough, Atypical pneumonia, Gait disturbance, Lung opacity, Rib fracture,

MESALAMINE, MESALAMINE,

26660889

US

Tremor, Gait disturbance, Visual impairment, Decreased appetite, Blood glucose increased, Incorrect dose administered,

ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE,

26661488

US

Gait disturbance,

26661534

US

Gait disturbance, Asthenia, Asthenia, Weight decreased, Fatigue,

ORAL SEMAGLUTIDE,

26661545

US

Hypoaesthesia, Regurgitation, Nerve injury, Balance disorder, Gait disturbance, Burning sensation, Paraesthesia,

OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM,

26662533

US

Psoriatic arthropathy, Blister rupture, Paraesthesia, Contusion, Condition aggravated, Gait disturbance, Dry skin, Sinusitis,

CLADRIBINE, CLADRIBINE, CLADRIBINE,

26662618

US

Arthralgia, Pain, Erythema, Rheumatoid arthritis, Gait disturbance, Procedural pain,

UPADACITINIB, UPADACITINIB, UPADACITINIB,

26663098

EU

Aortic aneurysm, Product container issue, Confusional state, Emotional disorder, On and off phenomenon, Freezing phenomenon, Bradykinesia, Muscle rigidity, Bowel movement irregularity, Catheter site bruise, Unintentional medical device removal, Fatigue, Depressed mood, Asthenia, Gait disturbance, Drug ineffective, Therapeutic product effect incomplete, Viral infection, Contrast media reaction, Device use error, Stress, Gait inability, Catheter site erythema,

FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, RIVAROXABAN,

26663308

CA

Blood pressure abnormal, Bronchitis, Chest pain, Diarrhoea, Eructation, Gait disturbance, General physical health deterioration, Illness, Influenza like illness, Ligament sprain, Limb injury, Muscular weakness, Peripheral swelling, Wound secretion, Productive cough, Scab, Thyroid hormones decreased, Injection site pain, Asthenia, Fatigue, Metastases to bone, Prostatic specific antigen increased,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE,

26663568

Gait disturbance,

RUXOLITINIB, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, GABAPENTIN, LISINOPRIL, SUMATRIPTAN, SUMATRIPTAN SUCCINATE,

26663637

US

Prostate cancer, Mental disorder, Pustular psoriasis, Rash papular, Skin exfoliation, Drug dose titration not performed, Gait disturbance, Peripheral swelling, Onychomadesis, Psoriasis, Psoriatic arthropathy, Skin fissures, Skin haemorrhage, Depression, Erythema, Drug ineffective,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, UPADACITINIB, UPADACITINIB,

26663741

US

Dizziness, Dysphonia, Gait disturbance, Diarrhoea, Constipation, Dyspnoea, Back pain, Productive cough,

ORAL SEMAGLUTIDE, CABOZANTINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, LORAZEPAM, MAGNESIUM, ERGOCALCIFEROL,

26663818

US

Constipation, Diarrhoea, Dizziness, Dysphonia, Dyspnoea, Gait disturbance, Back pain, Productive cough,

ORAL SEMAGLUTIDE, CABOZANTINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, MAGNESIUM, LORAZEPAM,

26663938

US

Dementia, Dyspnoea, Therapeutic response shortened, Carpal tunnel syndrome, Arthralgia, Gait disturbance,

VUTRISIRAN, TAFAMIDIS,

26664414

US

Spinal pain, Weight increased, Peripheral swelling, Gait disturbance, Pain in extremity, Pain, Nasopharyngitis, Product use in unapproved indication,

ORAL SEMAGLUTIDE,

26664746

US

Hospitalisation, Dyspnoea, Sputum increased, Fall, Multiple injuries, Gait disturbance, Product dose omission in error,

ENSIFENTRINE, ENSIFENTRINE,

26664987

US

Cerebrovascular accident, Hemiparesis, Hip fracture, Pelvic fracture, Weight decreased, Road traffic accident, Aggression, Arthritis, Balance disorder, Decreased appetite, Fall, Gait disturbance, Product use issue, Hypoaesthesia, Irritability, Limb discomfort, Muscular weakness, Paraesthesia, Peripheral coldness, Peripheral swelling, Vision blurred, Hypertonic bladder, Intervertebral disc protrusion, Muscle spasms, Arthralgia, Hypertension, Insomnia, Pain in extremity, Taste disorder, Asthenia, Hot flush, Depressed mood, Fatigue, Nocturia,

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, ENZALUTAMIDE, ENZALUTAMIDE, ENZALUTAMIDE, MELATONIN, AMLODIPINE BESYLATE, BACLOFEN, EZETIMIBE, GABAPENTIN, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,